Removing identifying information from patient data so that data cannot be linked to a specific person, mitigates privacy risks to individuals and reduces risk to the organization by minimizing the potential for data breaches. There is also no requirement to obtain authorizations/consents for use of de-identified data. De-identification thereby supports the secondary use of data for life sciences research as well as quality assurance, comparative effectiveness studies, precision medicine initiatives and other endeavors. De-identification attempts to balance the contradictory goals of using and sharing personal information while protecting privacy. Please note, use of de-identified data for Human Subject research, will still generally need IRB review. The Department of Health and Human Services (HHS) published a guidance document on November 26 2012: The HIPAA Privacy Rule and associated guidance provides two methods for de-identification of health information: De-identification leads to information loss which may limit the usefulness of the resulting health information in certain circumstances. This is particularly true for the safe harbor method which utilizes a strict, inflexible approach. The expert method takes a risk-based approach that applies current standards and best practices from de-identification research.
Copyright: 2024 University of Miami. All Rights Reserved.
Emergency Information
Privacy Statement & Legal Notices
Individuals with disabilities who experience any technology-based barriers accessing University websites can submit details to our online form.